Beyond in vitro results, WT1-pTj also revealed effectiveness in the in vivo context, curbing both metastatic and subcutaneous growth of murine melanoma in syngeneic mice, and enhancing survival rates in nude mice with human melanoma cells. The gene discussed is WT1; the disease is melanoma.